A Phase I Study to Evaluate the Safety and Immunogenicity of Simultaneous Prime-Boost Immunisations With Candidate HCV and HIV-1 Vaccines, AdCh3NSmut1 / ChAdV63.HIVconsv and MVA-NSmut / MVA.HIVconsv, in Healthy Volunteers

Trial Details:

I Ongoing
University of Oxford; ReiThera Srl; GlaxoSmithKline October 15, 2014
ChAdV63.HIVconsv ,MVA.HIVconsv ChimpAd63 consensus; MVA consensus; AdCh3NSmut1; MVA-NSmut
ChAdV63.HIVconsv Viral Vector - Adeno
MVA.HIVconsv Viral Vector - Pox
United Kingdom 32